Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-04 @ 7:14 AM
Study NCT ID:
NCT00685269
Status:
COMPLETED
Last Update Posted:
2012-02-22
First Post:
2008-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08
Start Date Type:
None
Primary Completion Date:
2004-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-23
First Submit QC Date:
None
Study First Post Date:
2008-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-21
Last Update Post Date:
2012-02-22
Last Update Post Date Type:
ESTIMATED